Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8016 USD | -2.52% | -1.99% | -60.71% |
May. 24 | B. Riley Cuts Price Target on Gritstone bio to $3 From $6, Keeps Buy Rating | MT |
May. 09 | Earnings Flash (GRTS) GRITSTONE BIO Posts Q1 Revenue $1.74M, vs. Street Est of $2.85M | MT |
Business Summary
Number of employees: 231
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Vaccine-based Immunotherapy
100.0
%
| 20 | 100.0 % | 16 | 100.0 % | -18.05% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 20 | 100.0 % | 16 | 100.0 % | -18.05% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Andrew Allen
FOU | Founder | 57 | 15-07-31 |
Director of Finance/CFO | 44 | 21-06-22 | |
Karin Jooss
CTO | Chief Tech/Sci/R&D Officer | 59 | 16-04-12 |
Erin Jones
COO | Chief Operating Officer | 52 | 16-04-30 |
Investor Relations Contact | - | 21-11-30 | |
James Cho
AUD | Comptroller/Controller/Auditor | - | 19-10-31 |
Human Resources Officer | - | - | |
Matthew Hawryluk
PRN | Corporate Officer/Principal | 46 | 15-10-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Allen
FOU | Founder | 57 | 15-07-31 |
Elaine Jones
CHM | Chairman | 69 | 19-09-11 |
Lawrence Corey
BRD | Director/Board Member | 77 | 22-08-11 |
Steve Krognes
BRD | Director/Board Member | 55 | 18-07-09 |
Naiyer Rizvi
FOU | Founder | 60 | - |
Shefali Agarwal
BRD | Director/Board Member | 50 | 21-05-31 |
Clare Fisher
BRD | Director/Board Member | 51 | 21-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 108,569,374 | 105,984,472 ( 97.62 %) | 0 | 97.62 % |
Company contact information
Gritstone bio, Inc.
5959 Horton Street Suite 300
94608, Emeryville
+510 871 6100
http://www.gritstonebio.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.71% | 87.03M | |
-2.13% | 90.02B | |
-0.66% | 39.15B | |
-15.83% | 31.71B | |
+62.42% | 26.47B | |
-21.68% | 14.34B | |
-8.73% | 12.89B | |
-10.32% | 11.18B | |
-45.77% | 10.97B | |
+3.45% | 8.94B |
- Stock Market
- Equities
- GRTS Stock
- Company Gritstone bio, Inc.